Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 69

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 69
---
 |
| Tycho Peterson(7)                                                |     |              |     14,094 |     |            |    * |
| Kyle Piskel(8)                                                   |     |              |    203,299 |     |            |    * |
| Sharon Benzeno, PhD(9)                                           |     |              |    635,402 |     |            |    * |
| Harlan Robins, PhD(10)                                           |     |              |  2,143,480 |     |            |  1.4 |
| Julie Rubinstein(11)                                             |     |              |  1,378,870 |     |            |    * |
| Michelle Griffin(12)                                             |     |              |    156,780 |     |            |    * |
| Robert Hershberg, PhD, MD(13)                                    |     |              |    203,992 |     |            |    * |
| Peter Neupert(14)                                                |     |              |    453,992 |     |            |    * |
| Katey Owen, PhD(15)                                              |     |              |    160,393 |     |            |    * |
| Michael Pellini, MD(16)                                          |     |              |    228,992 |     |            |    * |
| All directors and executive officers as a group (12 persons)(17) |     |              | 10,125,817 |     |            |  6.4 |

| * | Represents beneficial ownership of less than 1% |

| (1) | Based upon information set forth in a Schedule 13G/A jointly filed by Viking Global Investors LP (“VGI”), Viking Global Performance LLC (“VGP”), Viking Global Equities II LP (“VGEII”), Viking Global Equities Master Ltd. (“VGEM”), Viking Long Fund GP LLC (“VLFGP”), Viking Long Fund Master Ltd. (“VLFM,” |

55

| and together with all of the preceding entities, the “Viking Global Entities”), O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, with the SEC on February 14, 2024. The total amount of shares consists of (i) 21,562,143 shares held by VGEM, (ii) 440,046 shares held by VGEII and (iii) 7,991,519 shares held by V